CUAMC
BCYC icon

China Universal Asset Management Company’s Bicycle Therapeutics BCYC Stock Holding History

China Universal Asset Management Company’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5K Sell
7,420
-802
-10% -$3.68K ﹤0.01% 482
2026
Q1 		$38.1K Buy
8,222
+682
+9% +$3.9K ﹤0.01% 472
2025
Q4 		$53.4K Sell
7,540
-564
-7% -$4.16K ﹤0.01% 444
2025
Q3 		$62.7K Sell
8,104
-762
-9% -$5.75K 0.01% 416
2025
Q2 		$61.6K Buy
8,866
+33
+0.4% +$263 0.01% 407
2025
Q1 		$75K Sell
8,833
-496
-5% -$5.84K 0.01% 383
2024
Q4 		$131K Buy
9,329
+2,191
+31% +$47K 0.01% 367
2024
Q3 		$162K Buy
7,138
+2,918
+69% +$67.3K 0.02% 317
2024
Q2 		$85.4K Sell
4,220
-2,639
-38% -$59.6K 0.01% 311
2024
Q1 		$171K Buy
6,859
+2,858
+71% +$60.7K 0.02% 312
2023
Q4 		$72.3K Buy
4,001
+3,322
+489% +$55K 0.01% 322
2023
Q3 		$13.6K Buy
679
+340
+100% +$7.78K ﹤0.01% 326
2023
Q2 		$8.65K Sell
339
-10
-3% -$232 ﹤0.01% 327
2023
Q1 		$7.42K Buy
349
+90
+35% +$2.26K ﹤0.01% 332
2022
Q4 		$7.67K Buy
259
+20
+8% +$537 ﹤0.01% 252
2022
Q3 		$6K Buy
+239
New +$5.69K ﹤0.01% 246

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

China Universal Asset Management Company's BCYC Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Bicycle Therapeutics (BCYC) stake by 9.8% in Q2 2026, selling an estimated $3.68K and leaving 7,420 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

China Universal Asset Management Company first reported a position in BCYC in Q3 2022 and has held it in 16 quarters since. The position peaked at $171K in Q1 2024. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • China Universal Asset Management Company held 7,420 shares of Bicycle Therapeutics worth $31.5K as of Q2 2026.
  • China Universal Asset Management Company sold 802 Bicycle Therapeutics shares in Q2 2026, an estimated $3.68K.
  • Bicycle Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #482 holding.
  • China Universal Asset Management Company first reported a position in Bicycle Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Bicycle Therapeutics position peaked at $171K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.